BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9323061)

  • 1. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
    Christenson RH; Ohman EM; Topol EJ; Peck S; Newby LK; Duh SH; Kereiakes DJ; Worley SJ; Alosozana GL; Wall TC; Califf RM
    Circulation; 1997 Sep; 96(6):1776-82. PubMed ID: 9323061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
    Tanasijevic MJ; Cannon CP; Antman EM; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Braunwald E
    J Am Coll Cardiol; 1999 Sep; 34(3):739-47. PubMed ID: 10483955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
    Tanasijevic MJ; Cannon CP; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Antman EM; Braunwald E
    Am Heart J; 1997 Oct; 134(4):622-30. PubMed ID: 9351728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Laperche T; Steg PG; Dehoux M; Benessiano J; Grollier G; Aliot E; Mossard JM; Aubry P; Coisne D; Hanssen M
    Circulation; 1995 Oct; 92(8):2079-86. PubMed ID: 7554185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis.
    Zabel M; Hohnloser SH; Köster W; Prinz M; Kasper W; Just H
    Circulation; 1993 May; 87(5):1542-50. PubMed ID: 8491009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
    de Groot MJ; Muijtjens AM; Simoons ML; Hermens WT; Glatz JF
    Heart; 2001 Mar; 85(3):278-85. PubMed ID: 11179265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction.
    Vuotikka P; Uusimaa P; Niemelä M; Väänänen K; Vuori J; Peuhkurinen K
    Int J Cardiol; 2003 Oct; 91(2-3):137-44. PubMed ID: 14559123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
    Ohman EM; Christenson RH; Califf RM; George BS; Samaha JK; Kereiakes DJ; Worley SJ; Wall TC; Berrios E; Sigmon KN
    Am Heart J; 1993 Oct; 126(4):819-26. PubMed ID: 8213437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion.
    Laperche T; Steg PG; Benessiano J; Dehoux M; Juliard JM; Himbert D; Gourgon R
    Am J Cardiol; 1992 Nov; 70(13):1129-34. PubMed ID: 1414933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction.
    Stewart JT; French JK; Théroux P; Ramanathan K; Solymoss BC; Johnson R; White HD
    J Am Coll Cardiol; 1998 Jun; 31(7):1499-505. PubMed ID: 9626826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early behavior of biochemical markers in patients with thrombolysis in myocardial infarction grade 2 flow in the infarct artery as opposed to other flow grades after intravenous thrombolysis for acute myocardial infarction. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Laperche T; Golmard JL; Steg PG
    Am Heart J; 1997 Dec; 134(6):1044-51. PubMed ID: 9424064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial reperfusion can be predicted by myoglobin/creatine kinase ratio of a single blood sample obtained at the time of admission.
    Abe J; Yamaguchi T; Isshiki T; Naka H; Taguchi J; Ishizaka N; Kurokawa K; Saeki F; Ishizaka Y; Ui K
    Am Heart J; 1993 Aug; 126(2):279-85. PubMed ID: 8337996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy.
    Apple FS; Henry TD; Berger CR; Landt YA
    Am J Clin Pathol; 1996 Jan; 105(1):6-10. PubMed ID: 8561090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
    Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
    Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction.
    Giannitsis E; Müller-Bardorff M; Lehrke S; Wiegand U; Tölg R; Weidtmann B; Hartmann F; Richardt G; Katus HA
    Circulation; 2001 Aug; 104(6):630-5. PubMed ID: 11489766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
    Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
    J Am Coll Cardiol; 1999 Mar; 33(3):627-33. PubMed ID: 10080461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid diagnosis of coronary reperfusion by measurement of myoglobin level every 15 min in acute myocardial infarction.
    Miyata M; Abe S; Arima S; Nomoto K; Kawataki M; Ueno M; Yamashita T; Hamasaki S; Toda H; Tahara M
    J Am Coll Cardiol; 1994 Apr; 23(5):1009-15. PubMed ID: 8144762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial.
    Watanabe K; Nagao K; Watanabe I; Kanmatsuse K
    Circ J; 2004 Apr; 68(4):280-5. PubMed ID: 15056821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.